vs
Side-by-side financial comparison of Amarin Corp plc (AMRN) and SOUTH PLAINS FINANCIAL, INC. (SPFI). Click either name above to swap in a different company.
SOUTH PLAINS FINANCIAL, INC. is the larger business by last-quarter revenue ($54.1M vs $45.1M, roughly 1.2× Amarin Corp plc). SOUTH PLAINS FINANCIAL, INC. runs the higher net margin — 26.9% vs -23.3%, a 50.1% gap on every dollar of revenue. Over the past eight quarters, SOUTH PLAINS FINANCIAL, INC.'s revenue compounded faster (5.6% CAGR vs -18.3%).
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.
Ally Financial Inc. is an American bank holding company incorporated in Delaware and headquartered at Ally Detroit Center in Detroit, Michigan. The company provides financial services including car finance, online banking via a direct bank, corporate lending, vehicle insurance, mortgage loans, and other related financing services such as installment sale and lease agreements.
AMRN vs SPFI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $45.1M | $54.1M |
| Net Profit | $-10.5M | $14.5M |
| Gross Margin | — | — |
| Operating Margin | 35.5% | — |
| Net Margin | -23.3% | 26.9% |
| Revenue YoY | 7.0% | — |
| Net Profit YoY | 33.0% | 18.3% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.1M | $54.1M | ||
| Q4 25 | $49.2M | $53.9M | ||
| Q3 25 | $49.7M | $54.2M | ||
| Q2 25 | $72.7M | $54.7M | ||
| Q1 25 | $42.0M | $49.2M | ||
| Q4 24 | $62.3M | $51.9M | ||
| Q3 24 | $42.3M | $47.9M | ||
| Q2 24 | $67.5M | $48.6M |
| Q1 26 | $-10.5M | $14.5M | ||
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-7.7M | $16.3M | ||
| Q2 25 | $-14.1M | $14.6M | ||
| Q1 25 | $-15.7M | $12.3M | ||
| Q4 24 | $-48.6M | — | ||
| Q3 24 | $-25.1M | $11.2M | ||
| Q2 24 | $1.5M | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 35.4% | ||
| Q3 25 | -22.4% | 38.1% | ||
| Q2 25 | -22.0% | 34.1% | ||
| Q1 25 | -39.9% | 31.9% | ||
| Q4 24 | -84.3% | 39.9% | ||
| Q3 24 | -59.5% | 29.8% | ||
| Q2 24 | -0.8% | 29.3% |
| Q1 26 | -23.3% | 26.9% | ||
| Q4 25 | -2.5% | — | ||
| Q3 25 | -15.6% | 30.1% | ||
| Q2 25 | -19.4% | 26.7% | ||
| Q1 25 | -37.4% | 25.0% | ||
| Q4 24 | -78.0% | — | ||
| Q3 24 | -59.4% | 23.4% | ||
| Q2 24 | 2.3% | 22.9% |
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.90 | ||
| Q3 25 | $-0.02 | $0.96 | ||
| Q2 25 | $-0.03 | $0.86 | ||
| Q1 25 | $-0.04 | $0.72 | ||
| Q4 24 | $-0.12 | $0.96 | ||
| Q3 24 | $-0.06 | $0.66 | ||
| Q2 24 | $0.00 | $0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $307.8M | $722.0M |
| Total DebtLower is stronger | — | $3.0K |
| Stockholders' EquityBook value | — | $504.9M |
| Total Assets | $645.8M | $4.6B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $307.8M | $722.0M | ||
| Q4 25 | $302.6M | $552.4M | ||
| Q3 25 | $286.6M | $635.0M | ||
| Q2 25 | $298.7M | $470.5M | ||
| Q1 25 | $281.8M | $536.3M | ||
| Q4 24 | $294.2M | $359.1M | ||
| Q3 24 | $305.7M | $471.2M | ||
| Q2 24 | $306.7M | $298.0M |
| Q1 26 | — | $3.0K | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $504.9M | ||
| Q4 25 | $459.3M | $493.8M | ||
| Q3 25 | $458.9M | $477.8M | ||
| Q2 25 | $464.9M | $454.1M | ||
| Q1 25 | $473.7M | $443.7M | ||
| Q4 24 | $486.2M | $438.9M | ||
| Q3 24 | $531.4M | $443.1M | ||
| Q2 24 | $551.9M | $418.0M |
| Q1 26 | $645.8M | $4.6B | ||
| Q4 25 | $670.8M | $4.5B | ||
| Q3 25 | $659.8M | $4.5B | ||
| Q2 25 | $670.1M | $4.4B | ||
| Q1 25 | $655.7M | $4.4B | ||
| Q4 24 | $685.3M | $4.2B | ||
| Q3 24 | $750.6M | $4.3B | ||
| Q2 24 | $799.9M | $4.2B |
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
SPFI
| Net Interest Income | $42.9M | 79% |
| Noninterest Income | $11.3M | 21% |
